Home8F8 • FRA
add
SynAct Pharma AB
Previous close
€1.02
Day range
€0.92 - €0.96
Year range
€0.53 - €1.14
Market cap
530.75M SEK
Avg Volume
20.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.31M | -23.30% |
Net income | -20.49M | 35.73% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.66M | — |
Effective tax rate | 17.00% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.49M | 33.29% |
Total assets | 217.13M | -21.31% |
Total liabilities | 47.97M | -27.34% |
Total equity | 169.16M | — |
Shares outstanding | 41.30M | — |
Price to book | 0.25 | — |
Return on assets | -26.53% | — |
Return on capital | -33.85% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.49M | 35.73% |
Cash from operations | -24.08M | -64.31% |
Cash from investing | — | — |
Cash from financing | -124.00K | 18.95% |
Net change in cash | -24.31M | -56.40% |
Free cash flow | -18.36M | -490.35% |
About
Founded
Mar 14, 2012
Website
Employees
5
